Unknown

Dataset Information

0

Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.


ABSTRACT: Inhibiting lipogenesis prevents hepatic steatosis in rodents with insulin resistance. To determine if reducing lipogenesis functions similarly in humans, we developed MK-4074, a liver-specific inhibitor of acetyl-CoA carboxylase (ACC1) and (ACC2), enzymes that produce malonyl-CoA for fatty acid synthesis. MK-4074 administered to subjects with hepatic steatosis for 1 month lowered lipogenesis, increased ketones, and reduced liver triglycerides by 36%. Unexpectedly, MK-4074 increased plasma triglycerides by 200%. To further investigate, mice that lack ACC1 and ACC2 in hepatocytes (ACC dLKO) were generated. Deletion of ACCs decreased polyunsaturated fatty acid (PUFA) concentrations in liver due to reduced malonyl-CoA, which is required for elongation of essential fatty acids. PUFA deficiency induced SREBP-1c, which increased GPAT1 expression and VLDL secretion. PUFA supplementation or siRNA-mediated knockdown of GPAT1 normalized plasma triglycerides. Thus, inhibiting lipogenesis in humans reduced hepatic steatosis, but inhibiting ACC resulted in hypertriglyceridemia due to activation of SREBP-1c and increased VLDL secretion.

SUBMITTER: Kim CW 

PROVIDER: S-EPMC5603267 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.

Kim Chai-Wan CW   Addy Carol C   Kusunoki Jun J   Anderson Norma N NN   Deja Stanislaw S   Fu Xiaorong X   Burgess Shawn C SC   Li Cai C   Ruddy Marcie M   Chakravarthy Manu M   Previs Steve S   Milstein Stuart S   Fitzgerald Kevin K   Kelley David E DE   Horton Jay D JD  

Cell metabolism 20170801 2


Inhibiting lipogenesis prevents hepatic steatosis in rodents with insulin resistance. To determine if reducing lipogenesis functions similarly in humans, we developed MK-4074, a liver-specific inhibitor of acetyl-CoA carboxylase (ACC1) and (ACC2), enzymes that produce malonyl-CoA for fatty acid synthesis. MK-4074 administered to subjects with hepatic steatosis for 1 month lowered lipogenesis, increased ketones, and reduced liver triglycerides by 36%. Unexpectedly, MK-4074 increased plasma trigly  ...[more]

Similar Datasets

| S-EPMC4822632 | biostudies-literature
2023-03-05 | GSE226139 | GEO
| S-EPMC6986730 | biostudies-literature
2023-07-21 | PXD040481 | Pride
| S-EPMC1131783 | biostudies-other
| S-EPMC6251774 | biostudies-literature
| S-EPMC4833862 | biostudies-literature
| S-EPMC4060285 | biostudies-literature
| S-EPMC3264756 | biostudies-literature
| S-EPMC10594767 | biostudies-literature